Estrella Immunopharma, Inc. - ESLA

SEC FilingsOur ESLA Tweets

About Gravity Analytica

Recent News

    Recent Filings

    • 12.23.2024 - S-8 Securities to be offered to employees in employee benefit plans
    • 12.19.2024 - EFFECT Notice of Effectiveness
    • 12.17.2024 - 424B3 Prospectus [Rule 424(b)(3)]
    • 12.17.2024 - CORRESP Correspondence
    • 12.17.2024 - UPLOAD SEC-generated letter
    • 12.16.2024 - 8-K Current report
    • 12.12.2024 - S-3 Registration statement under Securities Act of 1933
    • 11.14.2024 - 10-Q Quarterly report [Sections 13 or 15(d)]
    • 10.28.2024 - 10-K/A Annual report [Section 13 and 15(d), not S-K Item 405]
    • 08.23.2024 - 3 Initial statement of beneficial ownership of securities